AUS
NZ
UK
CA
USA
IND
Highlights:
- Q3 sales decline to CAD 107.02 million, down 12.4% from 2023.
- Net loss for Q3 deepens to CAD 138.25 million, compared to CAD 81.28 million last year.
- Year-to-date net loss reaches CAD 308.22 million, a 46.3% increase from 2023.
NorthWest Healthcare Properties Real Estate Investment Trust (REIT) (TSX: NWH.UN), a leading owner and operator of healthcare real estate, has reported its earnings for the third quarter and the nine months ended September 30, 2024. The results reflect a challenging period for the company, with both sales and net income taking a hit due to various market conditions and strategic investments.
For the third quarter, NorthWest Healthcare posted CAD 107.02 million in sales, which marks a significant 12.4% decrease from CAD 122.18 million in the same quarter of 2023. The drop in sales was attributed to various factors, including property divestitures and reduced rental income from certain properties. Additionally, the company experienced a net loss of CAD 138.25 million for the quarter, compared to a loss of CAD 81.28 million in Q3 2023. This deeper net loss was largely driven by higher-than-expected financing costs, as well as some impairment charges on certain assets in the portfolio.
For the nine months ended September 30, 2024, NorthWest Healthcare reported total sales of CAD 359.7 million, down 6.3% from CAD 384.01 million in the same period last year. The decline in sales reflects both the divestitures mentioned earlier and lower-than-expected performance from certain healthcare properties in its portfolio. The company’s year-to-date net loss widened to CAD 308.22 million, compared to CAD 210.86 million in the same period of 2023, marking a 46.3% increase in the loss.
The primary contributors to the year-to-date loss were higher financing costs, which impacted the company’s overall profitability, as well as increased operating costs tied to property management and development initiatives. NorthWest Healthcare also made strategic investments in expanding its healthcare property portfolio, which led to increased capital expenditures and temporary cash flow pressures.
Despite the challenging financial results, NorthWest Healthcare’s management remains focused on its long-term strategy, which includes expanding its global healthcare property portfolio and enhancing its financial position through targeted acquisitions and strategic partnerships. The company continues to pursue growth opportunities in key international markets, particularly in Europe, where demand for healthcare real estate remains strong due to the aging population and rising healthcare needs.
"We are making significant strides in building a diverse and resilient healthcare real estate portfolio, despite the near-term challenges," said John Parkin, CEO of NorthWest Healthcare Properties REIT. "While our results for Q3 and the year-to-date period reflect some short-term headwinds, we are confident that our long-term strategy will deliver strong returns as we continue to expand and optimize our healthcare assets."
The company also emphasized its commitment to improving operational efficiencies and managing its debt levels in the face of a higher interest rate environment. The REIT’s management team is actively pursuing measures to improve cash flow generation, streamline costs, and enhance asset performance.
As of November 14, 2024, NorthWest Healthcare's stock traded at CAD 4.98, a decline of 0.80% over the past five days. Year-to-date, the stock has seen a decrease of 3.49%, reflecting broader market concerns around rising interest rates and inflationary pressures, which have impacted the real estate sector as a whole. However, analysts remain generally positive on the company’s long-term growth prospects, given its strong position in the healthcare real estate space and its focus on high-quality, income-generating properties.
